Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce that it has commenced the VISABL-VT clinical trial by completing the first-in-human ventricular ablation guided by real-time MRI with the Company’s NorthStar Mapping System. The procedure was performed by the team at the Amsterdam University Medical Centre (AUMC), ranked in 2025 by Newsweek as the best hospital in The Netherlands, and in the top 35 worldwide. This press release features multimedia. View the ful...

Frontline International, celebrating 25 years of innovation in commercial kitchen solutions, has appointed Giovanni Brienza as its new president. Founder John Palazzo will continue as CEO, focusing on strategic direction and long-term growth initiatives. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501026483/en/Giovanni Brienza, Frontline International President Frontline is a USA-based manufacturer of systems used globally by f...

Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the coordination of the ninth Special Olympics Airlift, a monumental event aimed at transporting hundreds of athletes and coaches across country to the 2026 Special Olympics USA Games in Minnesota’s Twin Cities. The company is calling on Cessna, Beechcraft and Hawker aircraft owners and operators to come together on Friday, June 19, 2026, and Saturday, June 27, 2026, to enable champions from all corners of the nation to t...

Telness Tech is excited to announce the availability of their services to Mobile Virtual Network Operators (MVNOs) on the T-Mobile network, one of the world’s most advanced mobile networks with nationwide 5G Standalone. This opportunity allows for the integration of Telness Tech’s BSS/OSS platform with T-Mobile’s 5G network, helping MVNOs in the U.S. to launch and grow their services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2025...

Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, today announced the final close of Sofinnova Biovelocita II. The fund has exceeded its target, successfully raising €165M, with substantial backing from the top global pharmaceutical companies, including Amgen, Bristol Myers Squibb, and Pfizer Ventures. This milestone marks a significant expansion of Sofinnova’s biotech acceleration strategy, extending beyond Italy to inclu...

Thales, today announced the findings of its 2025 Digital Trust Index – Consumer Edition, revealing a universal decline in trust for digital services compared to this time last year. Across 13 different sectors, only insurance, banking and Government saw either their trust level remain unchanged or increase very slightly. When asked which sector they trusted with their personal data, not one sector reached above 50% approval. Thales surveyed over 14,000 consumers across 14 countries about their ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced the completion of recruitment in the COMP005 phase 3 trial for treatment resistant depression (TRD). The final participants are completing pre-dosing activities, including washout from anti-depressant medications, if necessary, and those eligible will receive a dose of either 25 mg of COMP360 or placebo. “We are pleased that recruitment is complete...